| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/06/2004 | WO2004037229A1 Extended, controlled release pharmaceutical compositions comprising charged polymers |
| 05/06/2004 | US20040087547 Orally administered antitumor agents |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1181027B1 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/06/2004 | CA2503383A1 Extended, controlled release pharmaceutical compositions comprising charged polymers |
| 05/05/2004 | CN1494429A Aguatic animal treatment method and composition containing pimenta extract |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 04/29/2004 | WO2002066056A8 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 04/29/2004 | US20040082540 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 04/29/2004 | US20040081662 Vaccine |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/22/2004 | WO2004032949A1 Argyrolobium roseum plant extracts for treating diabetes |
| 04/22/2004 | WO2003063842A9 Composition for inhalation |
| 04/22/2004 | WO2002098857A8 New indole derivatives with 5-ht6 receptor affinity |
| 04/22/2004 | US20040077642 Pyrimidine compounds |
| 04/22/2004 | US20040076633 Genetic vaccines comprising a 1H-imidazo(4,5-c)- 4-amine derivative as an adjuvant, for increasing immune responses in a mammal to the encoded antigen |
| 04/22/2004 | CA2501935A1 Argyrolobium roseum plant extracts for treating diabetes |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1408953A1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/21/2004 | EP1154987B1 Phenylalaninol derivatives |
| 04/21/2004 | CN1146429C Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agent |
| 04/14/2004 | EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/14/2004 | EP1406870A1 Taxol enhancer compounds |
| 04/14/2004 | EP1406869A1 Taxol enhancer compounds |
| 04/14/2004 | CN1489592A 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/08/2004 | WO2004028521A2 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 04/07/2004 | EP1405852A1 Diamine derivatives |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404345A2 Skin-permeable selective cyclooxygenase-2 inhibitor composition |
| 04/07/2004 | EP1404309A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 04/07/2004 | EP1150991B1 Compositions for treating inflammatory response |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/01/2004 | WO2003099281A3 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes |
| 04/01/2004 | US20040063767 Reacting an alpha-substituted ketone with a cyclictetramine to form quaternaryammonium salt, reacting the salt with an acid to form alpha-amino ketone, reacting ketone with alpha-substitued acyl derivative in presence of a base |
| 04/01/2004 | US20040063717 Employing fatty acid oxidation inhibitor; lowering HbA1c, glucose, total cholesterol and/or triglyceride plasma levels; increasing high density lipoprotein concentration; minimizing side effects; ranolazine |
| 04/01/2004 | US20040063622 Methods and compositions for treating flaviviruses and pestiviruses |
| 03/31/2004 | EP1401828A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 03/31/2004 | EP1401813A1 New indole derivatives with 5-ht6 receptor affinity |
| 03/31/2004 | EP1401502A1 Pharmaceutical formulation |
| 03/31/2004 | EP1401485A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 4-(2- 4-methane sulfonyl oxyphenyl ethoxy)phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and insulin |
| 03/31/2004 | EP1401461A2 Selective cox-2 inhibition from edible plant extracts |
| 03/31/2004 | EP1181294B1 Novel derivatives and analogues of galanthamin |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/25/2004 | WO2003087050A3 Novel perindopril salt and pharmaceutical compositions containing same |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040058935 Crystals; storage stability; psychological disorders |
| 03/25/2004 | US20040058908 Mixture of bile acid transport inhibitor, cholesteryl ester transport protein inhibitor, fibric acid, nicotinic acid, microsomal triglyceride transfer protein inhibitor and sterols |
| 03/24/2004 | EP1399445A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 03/24/2004 | EP1399166A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- 4-(2- 4-METHANE SULFONYL OXYPHENYL ETHOXY) PHENYL] PROPANOIC ACID OR 3- 4- 2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA |
| 03/24/2004 | CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 03/18/2004 | US20040053986 3,7-Diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040052870 Cyclooxygenase (COX-2) inhibitors; for treatment/prevention of inflammation; nutraceuticals; for treatment of nervous system disorders |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1397133A1 Rapid onset formulation |
| 03/17/2004 | EP1397131A1 Compositions comprising nitrofurantoin and uva ursi |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/17/2004 | EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds |
| 03/16/2004 | US6706878 Spiroazabicyclic heterocyclic compounds |
| 03/11/2004 | WO2004019960A2 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/11/2004 | US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048846 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 03/11/2004 | CA2497161A1 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/10/2004 | CN1481387A Condensed purine derivatives as A1 adenosine receptor antagonists |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/09/2004 | US6703502 Spiroazo bicyclic heterocyclic |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 03/03/2004 | EP1392666A1 Biologically active methylene blue derivatives |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | CN1140535C Halo derivatives of 9-deoxo-9a-aza-9a-homery theromycin A. |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 02/26/2004 | US20040038957 Anti-malarial activity |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1390378A1 Pharmaceutically active uridine esters |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | CN1477975A Combination of GABA agonists and sorbitol dehydrogenase inhibitors |
| 02/25/2004 | CN1477970A 疫苗 Vaccine |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure |
| 02/19/2004 | US20040034230 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
| 02/18/2004 | EP1133477B1 Substituted benzimidazoles and their use as parp inhibitors |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |